IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The Company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems for veterinarians; and biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community.
It also offers diagnostic, health-monitoring, and food safety testing products for livestock, poultry, and dairy; products that test water for certain microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The Company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

Show more
Type
Public
HQ
Westbrook, US
Founded
1983
Size (employees)
7,600 (est)+4%
Website
idexx.com
IDEXX Laboratories was founded in 1983 and is headquartered in Westbrook, US
Report incorrect company information

Key People/Management at IDEXX Laboratories

Jay Mazelsky

Jay Mazelsky

Executive Vice President
Brian McKeon

Brian McKeon

Executive Vice President, Chief Financial Officer and Treasurer
Jacqueline Studer

Jacqueline Studer

Corporate Vice President, General Counsel and Secretary
Giovani Twigge

Giovani Twigge

Corporate Vice President and Chief Human Resources Officer
Jeff Dixon

Jeff Dixon

Corporate Vice President and Chief Software Engineering Officer
George Fennell

George Fennell

Corporate Vice President
Show more

IDEXX Laboratories Office Locations

IDEXX Laboratories has offices in Brookfield, Dallas, Jersey, Columbia and in 24 other locations
Westbrook, US (HQ)
1 Idexx Dr
Show all (28)
Report incorrect company information

IDEXX Laboratories Financials and Metrics

IDEXX Laboratories Financials

IDEXX Laboratories's revenue was reported to be $1.78 b in FY, 2016 which is a 10.8% increase from the previous period.
USD

Revenue (Q3, 2017)

492 m

Gross profit (Q3, 2017)

274 m

Gross profit margin (Q3, 2017), %

55.7%

Net income (Q3, 2017)

70.5 m

EBIT (Q3, 2017)

100.4 m

Market capitalization (20-Apr-2018)

17.6 b

Cash (30-Sep-2017)

169 m

EV

18.1 b
IDEXX Laboratories's current market capitalization is $17.6 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.4 b1.5 b1.6 b1.8 b

Revenue growth, %

8%8%11%

Cost of goods sold

711.6 m800 m

Gross profit

890.3 m975.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

338.3 m360.2 m390.1 m383.5 m382.5 m413.3 m406.4 m417.6 m466.6 m448.3 m462 m508.9 m492 m

Cost of goods sold

152.5 m158.1 m171.6 m170.2 m166.9 m180.6 m182.1 m190 m206 m201.6 m203.8 m216.2 m218 m

Gross profit

185.8 m202.1 m218.5 m213.3 m215.5 m232.8 m224.3 m227.5 m260.5 m246.7 m258.2 m292.7 m274 m

Gross profit Margin, %

55%56%56%56%56%56%55%54%56%55%56%58%56%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

279.1 m322.5 m129 m154.9 m

Inventories

133.4 m160.3 m188.8 m158 m

Current Assets

652.7 m759.4 m821.6 m845.6 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

264.8 m286.2 m305 m292.7 m182.2 m163.2 m141.2 m133 m141.1 m150.1 m160.4 m166 m169 m

Inventories

146 m141.1 m145.4 m156 m173.4 m184.5 m192.4 m183.8 m175.7 m168.5 m172.2 m169.7 m176.7 m

Current Assets

625.2 m683.2 m701.7 m702.6 m808.9 m833 m833.4 m809 m821.1 m828.1 m878.6 m918.7 m942.7 m

PP&E

274.2 m282.2 m286.7 m291.7 m309.8 m326 m320.3 m343 m347.2 m349.7 m361.2 m364.8 m367.5 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

187.8 m182 m192.1 m222.1 m

Depreciation and Amortization

54.6 m58.9 m69 m78.2 m

Inventories

(1.3 m)(38 m)(35 m)7.6 m

Accounts Payable

(4.4 m)6.7 m(2.5 m)2.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

45.7 m46.6 m57.2 m52.2 m46.6 m103.5 m147.7 m46 m113.2 m169.7 m69.1 m154.5 m225 m

Depreciation and Amortization

32.9 m51.2 m18.5 m38.2 m58 m20.3 m40.9 m61.6 m

Inventories

145.4 m156 m173.4 m(16 m)(27.2 m)1.8 m214 k(2.5 m)(5.4 m)(18.9 m)(23 m)

Accounts Payable

41.4 m58.3 m44.2 m(3 m)(2.8 m)(1.8 m)99 k(2.5 m)(3.7 m)1.4 m(3.5 m)
USDY, 2017

EV/EBIT

179.8 x

EV/CFO

71.6 x

Revenue/Employee

66.8 k
Show all financial metrics
Report incorrect company information